Skip to main content
. Author manuscript; available in PMC: 2021 Nov 15.
Published in final edited form as: J Immunol. 2020 Sep 30;205(10):2742–2749. doi: 10.4049/jimmunol.2000489

Figure 5.

Figure 5.

ADCC activity among pre- and post-treatment KS patients. 10 KS patients were tested for ADCC activity against lytically reactivated (A) and unstimulated (B) BC3 cells. Data shown is the mean and standard deviation from 3 independent experiments. Patients are coded by response status at follow up time point. Individuals with a reduced number and/or size of lesions at follow up are represented by green circles, those with no change after treatment are shown in blue triangles, and patients presenting new lesions are depicted with red squares. There was no change in ADCC pre- and post-treatment for the group as a whole, and the magnitude of response or change in response was not found to associate with treatment outcome.